Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Change in Account Payables (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Change in Account Payables for 4 consecutive years, with -$2.0 million as the latest value for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 934.69% year-over-year to -$2.0 million; the TTM value through Dec 2025 reached $471000.0, down 31.34%, while the annual FY2025 figure was $471000.0, 31.34% down from the prior year.
  • Change in Account Payables was -$2.0 million for Q4 2025 at Day One Biopharmaceuticals, down from $688000.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $4.4 million in Q1 2023, with the low at -$3.7 million in Q4 2022.
  • Historically, Change in Account Payables has averaged $124312.5 across 4 years, with a median of -$168000.0 in 2022.
  • The largest annual shift saw Change in Account Payables surged 2348.65% in 2024 before it tumbled 934.69% in 2025.
  • Over 4 years, Change in Account Payables stood at -$3.7 million in 2022, then surged by 78.05% to -$815000.0 in 2023, then soared by 130.06% to $245000.0 in 2024, then tumbled by 934.69% to -$2.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were -$2.0 million in Q4 2025, $688000.0 in Q3 2025, and $2.6 million in Q2 2025.